Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ISA Pharmaceuticals B.V.
DescriptionConjugate of 2 HPV type 16 E6 synthetic long peptides (SLPs) covalently linked to Amplivant, a synthetic toll-like receptor 1 (TLR1) and TLR2 ligand
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationHead and neck cancer
Indication DetailsTreat head and neck cancer in patients with HPV type 16 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today